Ionis Pharmaceuticals Inc Ionis (NASDAQ: IONS) and AstraZeneca Strike Deal to Develop and Commercialize Eplontersen Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) and AstraZeneca Plc (NASDAQ: AZN) both have inked an agreement to create and market Eplontersen. Eplontersen is a new antisense medicine of IONS for the